NCT05980416 2025-11-14Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2Elevation OncologyPhase 1 Terminated88 enrolled 18 charts
NCT02597036 2025-10-23A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid TumorsEli Lilly and CompanyPhase 1 Terminated62 enrolled 25 charts